Home » Industry Trends » 47 Biotech Industry Statistics, Trends and Analysis

47 Biotech Industry Statistics, Trends and Analysis

Biotech is the shortened word for biotechnology, which is technology based on biology. Biotech uses processes to develop technologies and products that help to improve our lives and our planet. It can be anything from biopharmaceutical drugs to food products and chemicals. In this post, we will share well-researched Biotech Industry Statistics along with Trends Analysis.

The biotech industry is always growing, especially with more developments in the modern and everyday world and being able to use the technology, to help our lives and the planet.

The United States dominates the biotech market, making around $112 billion in revenue every year. In Europe and the United States, there are over 700 public companies that represent the biotech industry, making a revenue of more than $140 billion a year. It’s obvious that the biotech industry makes a lot of money every year and is continuing to grow with the world and other developments being made.

47 Biotech Industry Statistics and Trends

#1. The global biotech market is expected to reach a value of $727.1 billion by 2025. With its constant growth in the developing world, it is likely to reach that value.

#2. It is expected that as the biotech market continues to grow, jobs will too. The expected rate that the biotech employment rate will grow by 5% between 20219 and 2029 and therefore continue to generate more and new jobs.

#3. As of 2016, the United States had the largest share in the biotech industry, standing at 73%.

#4. There are more than 800,000 biotech employees in the United States. The occupations can range from research to technical support.

#5. The biotech industry supports 4.7 million jobs across the United States. The biotech industry is always developing and growing and therefore, creating more and more jobs each year. Not only is this in the United States but globally too.

#6. There are currently around 6,653 biotech companies in the United States. Therapeutics is the most common industry in the biotech landscape making up 29.1% of all companies. This is followed by 17.6% analytics and diagnostics being the second prominent field in the biotech industry.

#7. Back in 2017, there was around $3.1 billion invested into biotech start-ups.

#8. On average, a biotechnologist makes around $80,455 a year. Some can earn less at $37,500 and on the other hand, some can earn up to $102,000 a year.

#9. In 2012, the percentage of biotechnology planting in the United States was 88% for corn, 93% for soy, and 94% for cotton. Biotech assisted the production of these crops and came close to completely replacing the normal crop farming.

#10. Flu vaccines contribute about $4 billion in revenue every year to the biotech industry. With this being something that we all need every year; it is guaranteed to continue contributing towards the revenue of the biotech industry.

#11. There are 5 multinational companies that make 80% of the vaccines that are used all around the world.

#12. 34% of people say that foods grown using biotech engineering, shouldn’t be used for human food and beverage products.

#13. 26% of Americans say they make it a priority to shop and buy foods, that haven’t been touched by biotechnology.

#14. Currently, there are around 246,000 clinical trials taking place and managed by the American biotech industry.

#15. All of the 50 states in the United States have at least one biotech trial under review.

#16. The earliest known example of biotechnology is around 9,000 years old.

#17. On average, it takes around 12 years for experimental drugs to go from the laboratory to the patient. This timescale includes processes such as testing and ensuring the drug causes no harm to the patient.

#18. Companies can spend over $314 million, just to get a drug onto the market.

#19. The antidepressant pharmaceutical market is expected to reach $16 billion in value by 2025. With a need for antidepressant medication, it is likely this will continue to grow over the years.

#20. Since 2001, the biotech industry and companies have had around 1.66 million people employed by them. It’s a great career to get into, as there are always lots of jobs and with the biotech industry constantly growing, people are always needed. As well as this, on average you get paid a good salary.

#21. Back in 2019, there was an average of 87,500 biotechnology jobs. The job market for biotechnology seems to be growing at above-average rates. Therefore, it is expected that there will be around 4,300 more jobs in the biotechnology sector, by 2029.

#22. Around 68% of people felt worried about biotechnology human enhancement, back in 2016.

#23. In regards to public concerns around biotechnology, 57% of Americans believe that GMO food is unsafe. Only a few people believe that biotech will help to solve world hunger or disease outbreak.

#24. Relating to GMOs, there are 1,783 studies that show it is safe. Scientific research has categorically proved that GMOs are safe and have all of these studies, to back this.

#25. Genetically engineered foods use around 130 million acres to be grown on. The growth of biotech plants has surged from 3.6 million acres in 1996 to 130 million acres in 2018.

#26. Some of the biggest growers for biotech plants are China, South Africa, Canada, Germany, Australia, Argentina, and Spain.

#27. Genetic modifications by the biotech industry, have made an average increase in crop yields by 22%. The outcome of this has helped to increase the profits of farmers by 68%. With the developing world, it is likely that these margins will become even higher.

#28. India and China are currently leading in the global biotech industry and are expected to continue leading. They are responsible for over 10% of the total capacity found worldwide.

#29. These 2 countries currently have a bioreactor volume of 1.8 million litres which can support ongoing development opportunities.

#30. 22% of Americans say they started to drink less coffee each day due to their concerns over genetic engineering by the biotech industry.

#31. A common trend that has been seen, is the concern that people have over genetic engineering and the biotech industry. They are worried that anything touched by the biotech industry, shouldn’t be consumed by humans.

#32. A continuing trend in the biotech industry is the continued improvement and development of drug research. Smart technology allows the possibility of improving and assessing diagnosis and treatments. It is thought that there will be a boost in the integration of assessment devices on methods such as MRI scans and lab equipment.

#33. There are ongoing and developing laws, regulations, and protocols that need to be passed with biotech products and the way they are produced. More companies are starting to show off what they do with live demos, so the consumer can see the real value of the products being produced. This makes the pricing of biotech products more value-based.

#34. Another trend is the focus on immune cell function. Immunity is a growing study under biotech, to help prevent the spread of harmful diseases. There has been an increase in the interest and study of immune cell function, which will have a big effect on immunotherapy.

#35. The top pharmaceutical companies in the top 10 ranks, in the United States are in New Jersey and Connecticut. Some of the top companies include Pfizer, Johnson & Johnson, and New Brunswick.

#36. An upcoming trend that a lot of biotech industries are warming to is gene therapy. Lots of biotech companies are investing in gene therapy, but the one challenge that stays is trying to prevent tragedies, with clinical trials. This is something that is likely to stay for the year, but something that all biotech companies are keen to prevent.

#37. According to Alliance for Regenerative Medicine, in the third quarter of 2020, gene therapy financing almost tripled year over year, rising 175% to $3.5 billion. January to September 2020 saw the financing jump 114% to $12 billion.

#38. The Alliance also recorded that in the third quarter of 2020, there were 373 gene therapy trials. This was up by 4% of 359 in the second quarter of 2020 and 370 reported trials in the third quarter of 2019.

#39. There are currently more than 300 biotech drug products and vaccines in clinical trials. They target more than 200 diseases including cancers, Alzheimer’s disease, diabetes, arthritis, and many more.

#40. Biotech is responsible for hundreds of medical diagnostic tests, including pregnancy tests. All of these products keep the blood supply safe from AIDS and can detect other conditions early on, so they can be treated successfully.

#41. Environmental biotech products make it possible to clean up hazardous waste more efficiently. This is done by harnessing pollution-eating microbes without using any caustic chemicals.

#42. DNA fingerprinting is a type of biotech process, which has developed over the years for criminal investigation and forensic medicine. This is something that will continue to be used for many years and progress and advance, as the world does.

#43. The biotechnology industry is one of the most research-intense industries in the world. Back in 2003, the United States spent an average of $17.9 billion on research and development.

#44. The biotech industry has lots of regulations to follow, they are regulated by the US Food and Drug Administration (FDA), the Environmental Protection Agency (EPA), and the Department of Agriculture (USDA). All biotech companies and industries need to follow these regulations.

#45. Industrial biotech has led to cleaner processes that can produce less waste and use less energy and water.

#46. There are overall benefits, including environmental and social, with biotech crops. In 2011, the use of biotech crops reduced CO2 emissions by 23.1 billion kilograms. That’s the equivalent of removing 10.2 million cars from the world’s roads.

#47. They have also saved 108.7 million hectares of land and lifted 15 million rural farmers and families out of poverty.

Biotech Industry Trends Analysis

As we have seen the biotech industry is always growing and developing, not only producing lots of money in revenue each year but developing new research and products. There are many benefits to the biotech industry, however, not everyone agrees with it.

Many people are afraid to use things that have been touched by the biotech industry and believe, we shouldn’t be putting it into our bodies. However, this hasn’t stopped the biotech industry from growing and developing more and moreover the years.

Although some people may disagree with it, there are some great benefits from the biotech industry. The industry not only produces and develops new drugs and products to help with our health but also environmentally they help the world out too.

The biotech industry is always growing and will continue to do so. It’s important to focus on the different trends within the industry, to keep up with the everyday world and ensure that biotech is helping people out, as well as the world. Some common trends can be seen in pharmaceutical drugs and environmental biotech industries.

As the world continues to grow and faces more and more issues relating to health, poverty, and the environment, it’s a great opportunity for biotech industries. Now is the time to be developing new drugs and products and to help out with the common problems, that the world faces daily.

A lot of money and research goes into this industry, in order for them to keep developing. Along with this, it also creates more jobs for people across the world. In the United States, the industry employs many people and pays them a good salary too. So, we have seen just how massive the biotech industry is and the power they have.

They are always investing, growing, and developing. Although some people may disagree with biotech products, there is so much proof there to show that it is helping people, diseases, health problems and also helping the environment and world too. It’s not something we can ignore and is a great industry, for future generations and for the future of the planet.